Syncor International to Invest in New Product
- Share via
Syncor International Corp. said it will make a $14-million investment in the development and distribution of a new type of diagnostic tool for detecting lung and breast cancer over the next three years.
The product, called positron emission tomography, is an extension of the kind of radio-pharmaceutical product the company already sells. Syncor expects to set up 24 distribution centers for it nationwide.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
